Showing results (1151-1160 of 1,519) with videos related to
Sort By:
Pageof 152
Familial Cancer|January 24, 2009
Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancerKristen M Drescher, Poonam Sharma, Patrice Watson, et al.Familial Cancer|February 3, 2009
Health behaviors among Ashkenazi Jewish individuals receiving counseling for BRCA1 and BRCA2 mutationsJackie Quach, Kyle Porter, Howard Leventhal, et al.Familial Cancer|September 16, 2010
CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in PolandAnna Jakubowska, Małgorzata Lawniczak, Beata Wojnarska, et al.Familial Cancer|March 19, 2011
Progression of duodenal adenomatosis in familial adenomatous polyposis: due to ageing of subjects and advances in technologyElisabeth M H Mathus-Vliegen, Karam S Boparai, Evelien Dekker, et al.Familial Cancer|March 25, 2011
A putative Lynch syndrome family carrying MSH2 and MSH6 variants of uncertain significance-functional analysis reveals the pathogenic oneJukka Kantelinen, Thomas V O Hansen, Minttu Kansikas, et al.Familial Cancer|March 16, 2011
Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristicsHeli J LehtonenFamilial Cancer|February 15, 2011
Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutationsThomas V O Hansen, Lars Jønson, Ane Y Steffensen, et al.Familial Cancer|August 7, 2016
Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohortElisabeth Jarhelle, Hilde Monica Frostad Riise Stensland, Lovise Mæhle, et al.Familial Cancer|August 3, 2016
Community attitudes towards a Jewish community BRCA1/2 testing programNicole Cousens, Rajneesh Kaur, Bettina Meiser, et al.Familial Cancer|June 26, 2015
Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front linesRebecca K Marcus, Jennifer L Geurts, Jessica A Grzybowski, et al.Pageof 152